DK1833495T3 - Dermatological use of milk proteins - Google Patents

Dermatological use of milk proteins

Info

Publication number
DK1833495T3
DK1833495T3 DK06716688T DK06716688T DK1833495T3 DK 1833495 T3 DK1833495 T3 DK 1833495T3 DK 06716688 T DK06716688 T DK 06716688T DK 06716688 T DK06716688 T DK 06716688T DK 1833495 T3 DK1833495 T3 DK 1833495T3
Authority
DK
Denmark
Prior art keywords
milk proteins
dermatological use
dermatological
milk
proteins
Prior art date
Application number
DK06716688T
Other languages
Danish (da)
Inventor
Angela Loriann Walter
Waard Rick De
Original Assignee
Campina Nederland Holding Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Campina Nederland Holding Bv filed Critical Campina Nederland Holding Bv
Application granted granted Critical
Publication of DK1833495T3 publication Critical patent/DK1833495T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Dairy Products (AREA)
  • Cosmetics (AREA)
DK06716688T 2005-03-15 2006-03-14 Dermatological use of milk proteins DK1833495T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05102043 2005-03-15
PCT/NL2006/050055 WO2006098625A1 (en) 2005-03-15 2006-03-14 Dermatologic use of milk proteins

Publications (1)

Publication Number Publication Date
DK1833495T3 true DK1833495T3 (en) 2008-06-02

Family

ID=34938984

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06716688T DK1833495T3 (en) 2005-03-15 2006-03-14 Dermatological use of milk proteins

Country Status (12)

Country Link
US (1) US8147875B2 (en)
EP (1) EP1833495B1 (en)
JP (2) JP2008533134A (en)
KR (1) KR101242428B1 (en)
CN (1) CN101166535A (en)
AU (4) AU2006223754B2 (en)
DE (2) DE212006000025U1 (en)
DK (1) DK1833495T3 (en)
ES (1) ES2301152T3 (en)
RU (1) RU2445105C2 (en)
TW (1) TWI383797B (en)
WO (1) WO2006098625A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006055210A1 (en) * 2006-11-21 2008-05-29 Ionescu, John G., Dr. Dietary food with increased free radical binding effect
ES2542529T3 (en) * 2008-06-16 2015-08-06 Campina Nederland Holding B.V. Aqueous composition of thermally stable lactoferrin and its preparation and use
EP2251032A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and protection in adults
JP5897783B2 (en) * 2009-12-24 2016-03-30 株式会社ロッテ Antiandrogen and sebum secretion inhibitor
PT2645993T (en) * 2010-12-03 2017-03-03 Allergan Inc Pharmaceutical cream compositions comprising oxymetazoline
WO2012112566A1 (en) 2011-02-15 2012-08-23 Allergan, Inc. Pharmaceutical cream compositions of oxymetazoline for treating symptoms of rosacea
KR101293490B1 (en) * 2012-03-16 2013-08-07 하월규 Food compositon for inhibiting secretion of sebum and for reducing acne comprising egg white hydrolysate and lactoferrin
ITMI20122152A1 (en) * 2012-12-17 2014-06-18 Progine Farmaceutici S R L COMPOSITION FOR TOPICAL USE.
US10307466B2 (en) * 2014-03-10 2019-06-04 Saraya Co., Ltd. Composition comprising sophorolipid, physiologically active substance and oil or fat, and method for producing the same
MX2016016400A (en) 2014-06-11 2017-06-12 Allergan Inc Stabilized oxymetazoline formulations and their uses.
FR3083981B1 (en) * 2018-07-20 2021-01-15 Semiocare Sas COMPOSITIONS FOR COSMETIC AND DERMATOLOGICAL USE
WO2024121317A1 (en) * 2022-12-08 2024-06-13 Frieslandcampina Nederland B.V. Process for producing a lactoferrin-containing product

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264980A (en) * 1989-08-02 1993-11-23 Seagate Technology, Inc. Magnetoresistive head and head setting method
JP2673320B2 (en) * 1990-01-25 1997-11-05 雪印乳業株式会社 Anti-cariogenic agent attachment inhibitor
JPH0458871A (en) * 1990-06-26 1992-02-25 Snow Brand Milk Prod Co Ltd Aging preventing food
JP3184923B2 (en) * 1992-01-08 2001-07-09 ビオ セレ ラボラトワール エス ア Anti-rheumatic drug
JPH05202098A (en) 1992-01-29 1993-08-10 Snow Brand Milk Prod Co Ltd Production of physiologically active substance from lactic material
JP3173859B2 (en) * 1992-05-01 2001-06-04 森永乳業株式会社 Liquid or liquid food
JP2832517B2 (en) 1994-12-09 1998-12-09 雪印乳業株式会社 Escherichia coli adhesion inhibitor
JP3183378B2 (en) * 1995-06-28 2001-07-09 参天製薬株式会社 Mucin production promoter
WO1998030235A1 (en) * 1997-01-09 1998-07-16 Morinaga Milk Industry Co., Ltd. Lactoferrin tablets
JP2001519815A (en) 1997-04-10 2001-10-23 エイジェニックス・インコーポレイテッド Use of lactoferrin in the treatment of allergen-induced disorders
FR2767697B1 (en) * 1997-09-01 2000-05-05 Boots Co Plc DERMATOLOGICAL COMPOSITION FOR PREVENTING THE APPEARANCE OF SKIN HYPERSENSITIVITY AND INTOLERANCE SYMPTOMS
FR2781150B1 (en) * 1998-07-17 2001-11-23 Jean Noel Thorel COMPOSITION FOR TOPICAL USE, COMPRISING THREE ACTIVE INGREDIENT PRINCIPLES
US20020054917A1 (en) * 1998-08-14 2002-05-09 Gohlke Marcus B. Compositions comprising beta glucan and lactoferrin, and methods for their use
US6258383B1 (en) * 1998-08-14 2001-07-10 Lactoferrin Products Company Dietary supplement combining colostrum and lactoferrin in a mucosal delivery format
JP3920505B2 (en) * 1999-08-16 2007-05-30 カルソニックカンセイ株式会社 Injection mold
JP2001089397A (en) * 1999-09-17 2001-04-03 Morinaga Milk Ind Co Ltd Physiologically active substance-containing tablet and method of preparing the same
ATE293895T1 (en) * 1999-10-29 2005-05-15 Hunza Di Pistolesi Elvira E C FIBROUS LIPO NUTRITIONAL COMPLEXES AND COMPOSITIONS CONTAINING SAME
JP4679687B2 (en) * 2000-02-16 2011-04-27 雪印乳業株式会社 Liver function improving agent
US6482396B1 (en) * 2001-05-15 2002-11-19 Campina Melkunie B.V. Methods for treating or preventing diseases of the oral cavity
FR2841747B1 (en) * 2002-07-02 2004-08-20 Cie Laitiere Europeenne MILK PROTEIN ISOLATE AND PROCESS FOR ITS PREPARATION
US20040214750A1 (en) * 2003-04-28 2004-10-28 Georgiades Izolda M. Medicaments for healing skin conditions in humans

Also Published As

Publication number Publication date
US8147875B2 (en) 2012-04-03
TW200719908A (en) 2007-06-01
ES2301152T3 (en) 2008-06-16
WO2006098625A1 (en) 2006-09-21
TWI383797B (en) 2013-02-01
AU2008100924B4 (en) 2009-05-21
AU2008100926A4 (en) 2008-10-23
CN101166535A (en) 2008-04-23
AU2006223754B2 (en) 2008-11-06
DE212006000025U1 (en) 2008-01-03
RU2007137845A (en) 2009-04-20
JP2010100627A (en) 2010-05-06
EP1833495B1 (en) 2008-02-06
DE602006000511T2 (en) 2009-01-29
DE602006000511D1 (en) 2008-03-20
AU2008100924A4 (en) 2008-10-23
US20080193551A1 (en) 2008-08-14
AU2008100926B4 (en) 2008-11-06
KR101242428B1 (en) 2013-03-12
JP2008533134A (en) 2008-08-21
RU2445105C2 (en) 2012-03-20
KR20070110518A (en) 2007-11-19
EP1833495A1 (en) 2007-09-19
AU2006223754A1 (en) 2006-09-21
AU2009100377A4 (en) 2009-05-28

Similar Documents

Publication Publication Date Title
DK1833495T3 (en) Dermatological use of milk proteins
CY2016029I1 (en) SUBTILYSIN KEKIN-TYPE 9 (PCSK9) ANTIGEN-BINDING PROTEIN-CONVERTING PROTEIN
DK1999154T3 (en) MANUFACTURED HETERODIMERED PROTEIN DOMAINS
DK1962886T4 (en) STABLE PROTEIN FORMULATIONS
DK1931702T3 (en) silk Proteins
CY2013046I2 (en) NOVEL USE OF IL-1BHTA ANTIBODIES
NO20055643D0 (en) Preparation of lodixanol
DK2219469T3 (en) MODIFICATION OF ENZYMATICALLY DISPOSED PROTEINS
FR2874166B1 (en) SURGICAL CLIP
DK1809660T3 (en) THYMUS-SPECIFIC PROTEIN
NO20043305D0 (en) Preparation of lodixanol
ITVI20050007U1 (en) SURGICAL FIXING FORCEPS
DK2119472T3 (en) Skin / hårbehandlingssystem
FI20055133A0 (en) Type of device
ITMI20040586A1 (en) COMPLEX EMULSIONS OF PERFLUOROPOLYETERS
DK2238159T3 (en) Hitherto unknown protein
SE0601411L (en) Preparation procedure
FR2877833B1 (en) CORRECTEUR OF LORDOSES
DK2301576T3 (en) Therapeutic use of anti-CS1 antibodies
FR2879145B1 (en) REMOVABLE FIXATION
AT501087A3 (en) MEDICAL ANGLE PIECE
ES1061344Y (en) DIAPER
FI20055256A (en) Bone proteins
FI20055258A (en) Bone Proteins
FI20055257A0 (en) Bone Proteins